***URGENT DRUG RECALL NOTICE - Sterile Eye Drops***
May 1st, 2026
VIA EMAIL
Dear Valued Customer:
This is to inform you of a voluntary product recall involving:
| Hilco Vision Item Number |
1302822 |
| Product Name |
Optase Dry Eye Intense Drops |
| Package Description |
0.33 fl. Oz (10mL), Sterile x 300 drops |
| Brand Name |
Optase |
| NDC |
72972-002-01 |
Please note: Only the affected lots listed below are eligible for return. Products outside these lots will not be accepted for credit. All product returns should be sent back in the original product packaging with lot numbers visible. We cannot credit back returns without lot numbers. If you’d like to place an order for unaffected lots, we’d be happy to assist.
| Lot |
Expiration Date |
| 8T98, 9T31, 9T32 |
30/04/26 |
| 2V13, 2V14, 2V15 |
30/06/26 |
| 3V35 |
31/08/26 |
| 3V36, 3V37 |
30/09/26 |
| 5V45, 5V46, 9V12 |
31/03/27 |
| 1X57, 1X70, 1X84 |
31/05/27 |
The lot number is located on the top of the product carton as shown in Attachment 1.
Hilco Vision is communicating the following recall notice on behalf of the manufacturer, Scope Health. Scope Health has initiated this recall to the retail level following FDA observations noted during a January 22, 2026 inspection of their former manufacturing partner, Fareva Excelvision (France). Scope Health has indicated that they terminated their relationship with this manufacturer in 2025 after the partner did not meet their performance expectations. This recall is being conducted out of an abundance of caution. No other Scope Health products, or lots of this product other than those identified above, are impacted by this recall.
Please note that batches with the format 200## (where # represents a number) are NOT affected, as they were manufactured by Scope Health’s new, unaffected contract manufacturer.
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
Actions
Required: |
Hilco Vision notified its customers via email on April 23, 2026, with the following instruction: "You are required to return all products from the affected lots in your possession." To implement this recall, please complete the attached verification form and follow these instructions:
- REVIEW inventory for the affected product code and check the packaging lot number to verify the product is affected.
- COMMUNICATE with all retailers to whom Optase Dry Eye Intense drops were distributed.
- SEGREGATE and quarantine all affected product upon review of inventory.
- DISSEMINATE Hilco Vision notice to all departments that handle the affected products.
- NOTIFY any customers to whom they may have distributed or forwarded the affected product about this voluntary recall.
- RETURN the acknowledgment form by completing this online form. Hilco Vision will send you an RMA and shipping label to return the affected product.
|
The affected product was shipped to you from our distribution center between May 2024 and December 2025.
Please immediately examine your inventory and quarantine the product subject to recall.
If you identify any units from the affected lots, please contact us using the details below and provide the quantities and lot information for the impacted stock.
We apologize for any inconvenience this action may cause. We appreciate your prompt attention to this matter and your cooperation in carrying out the instructions associated with this recall. Hilco Vision is committed to maintaining the safety and quality of the products we distribute and to preserving your confidence in our products.
Respectfully,
David C. Hufnagle, Ph.D.
Vice President of Global QARA